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Abstract
Objectives This systematic review was undertaken to define
the diagnostic performance of in utero MR (iuMR) imaging
when attempting to confirm, exclude or provide additional
information compared with the information provided by pre-
natal ultrasound scans (USS) when there is a suspicion of
foetal brain abnormality.
Methods Electronic databases were searched as well as rele-
vant journals and conference proceedings. Reference lists of
applicable studies were also explored. Data extraction was
conducted by two reviewers independently to identify relevant
studies for inclusion in the review. Inclusion criteria were
original research that reported the findings of prenatal USS
and iuMR imaging and findings in terms of accuracy as
judged by an outcome reference diagnosis for foetal brain
abnormalities.
Results 34 studies met the inclusion criteria which allowed
diagnostic accuracy to be calculated in 959 cases, all of which
had an outcome reference diagnosis determined by postnatal
imaging, surgery or autopsy. iuMR imaging gave the correct
diagnosis in 91 % which was an increase of 16 % above that
achieved by USS alone.
Conclusion iuMR imaging makes a significant contribution
to the diagnosis of foetal brain abnormalities, increasing the
diagnostic accuracy achievable by USS alone.
Key points
• Ultrasound is the primary modality for monitoring foetal
brain development during pregnancy
• iuMRI used together with ultrasound is more accurate for
detecting foetal brain abnormalities
• iuMR imaging is most helpful for detecting midline brain
abnormalities
• The moderate heterogeneity of reviewed studies may com-
promise findings
Keywords Ultrasound . Prenatal diagnosis .Magnetic
resonance imaging . Foetal . Brain malformations
Abbreviations
iuMR in utero magnetic resonance
ORD outcome reference diagnosis
PRISMA Preferred Reporting Items for Systematic
Reviews and Meta-Analyses
PROSPERO International Prospective Register of
Systematic Reviews
USS ultrasound scanning
Introduction
Abnormalities of the foetal brain occur in approximately 25
per 10,000 births in the UK [1] and can result from environ-
mental, chromosomal, genetic or acquired causes. Accurate
diagnosis of foetal brain abnormalities is necessary to guide
management of the pregnancy and facilitate parental
counselling.
Ultrasound scanning (USS) is the primary diagnostic im-
aging method for screening of the pregnancy and considered
the reference standard for imaging the foetus brain. There are
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occasions when technical limitations hinder clear visualisation
of the foetal anatomy [2, 3] which led to the exploration of
other diagnostic tests to supplement USS.
Advances in MR technology have meant initial technical
restrictions in imaging the foetus with in utero magnetic reso-
nance (iuMR) imaging have been overcome, experience with-
in radiology has increased and a growing body of literature
confirms increasing use of iuMR in diagnosing foetal brain
abnormalities [4–7]. Despite this, the true clinical value of
iuMR has not been established. Previous limited statistical
evidence was unable to demonstrate, in terms of diagnostic
accuracy, any benefit [8].
To our knowledge, there have been only two other recently
published systematic reviews in which Rossi and van Doorn
aimed to clarify the additional benefit ofMRI in the diagnostic
pathwaywhen used in addition to USS [9, 10]. Rossi reviewed
13 studies and van Doorrn selected 27 studies for review.
Despite similar aims and inclusion criteria only seven studies
were included in both reviews. This could, along with date
differences for searches, be due to the differences in exclusion
criteria. The criteria used byRossi excluded studies without an
outcome reference diagnosis (ORD), non-English publica-
tions and those where data were reported in graphs or percent-
ages. Van Doorns review excluded studies with a sample size
of less than 20 and studies where diagnoses were inadequately
described. We felt a new systematic review was justified in
order to update the existing, to attempt to limit the number of
studies excluded and to identify any other studies which may
have been erroneously excluded.
The aim of this study is to answer the following question: Is
the diagnostic accuracy of iuMR superior, equivalent or infe-
rior to USS?We aimed to assess diagnostic accuracy of iuMR
following antenatal USS through:
(a) Measurement of diagnostic accuracy of antenatal USS
alone (i.e. prior to iuMR) in relation to an ORD determined by
postnatal imaging, surgery or post-mortem examination
(b) Measurement of diagnostic accuracy of iuMR (follow-
ing antenatal USS) relative to an ORD
Secondary aims were to determine if counselling and/or
management of the pregnancy changes as a result of iuMR
imaging and to identify the foetal brain anomalies for which
iuMR is most useful.
Methods
Protocol
The protocol was written in accordance with the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) [11] and registered with the International
Prospective Register of Systematic Reviews (PROSPERO,
CRD42015010265).
Eligibility criteria
All study designs were considered eligible apart from case
reports, reviews or commentaries.
Participants
Pregnant women who had undergone, due to suspicion of a
brain abnormality, prenatal ultrasound and subsequent prena-
tal iuMR of their foetus’ brain and any findings confirmed by
an ORD.
Reference standard
Reference standards accepted to confirm the outcome diagno-
sis were postnatal imaging (transcranial US, MRI or CT) and
surgery or, in cases of foetal demise or neonatal death, autopsy
and post-mortem MR imaging.
Exclusions
Studies not reported in English and translation was unavail-
able. If an English abstract was available these were
scrutinised for relevant information, but limited data meant
adherence to the inclusion criteria could not be certain.
Search methods
We identified all studies in which iuMR imaging was used to
supplement USS for imaging foetal brain abnormalities in
utero using a sensitive search strategy of the following elec-
tronic databases using MesH and free-text terms as detailed in
Appendix 1, adapting the strategy for each database.
Databases searched were Medline (via OVID) (1966 to
present), EMBASE (via OVID) (1980 to present), Cochrane
Register of Diagnostic Test Accuracy Studies (accessed 18/
03/2015 and 02/10/2015) and Web of Science (1900 to pres-
ent). In addition, we searched relevant journals, conference
proceedings and examined reference lists of relevant and in-
cluded studies.
Electronic searches were conducted inMarch 2015 without
date restriction and later updated to identify all relevant papers
up to September 2015.
Data collection
Selection of studies
Screening of citations was completed independently by two
reviewers (DJ, CM). Any disagreements were resolved by
consensus. Where only abstracts were available, attempts
were made to contact authors for full reports. If the same data
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had been published in more than one publication, the most up
to date or complete study was selected.
A PRISMA flowchart was used to document and report
any decisions made during the study selection process [9]
(Fig. 1).
Assessment of methodological quality of included studies
Included studies were assessed independently for methodical
quality (DJ and CM) using a modified Quality Assessment of
Diagnostic Accuracy Studies (QUADAS 2) tool [12]. Studies
were rated in terms of bias risk and applicability using signal-
ling questions to score the four key domains—Patient selec-
tion, Index tests, Reference standard and Flow and Timing.
Studies were scored as BYes^, BNo^ or BUnclear^ for each
checklist item. Additional signalling questions were intro-
duced for both study design and index tests. These were to
determine prospective versus retrospective design and details
regarding USS and iuMR technique and reporting as these
were elements considered likely to introduce bias.
Data items and analysis
Study characteristics and outcomes were extracted indepen-
dently (DJ and CM) and recorded using a data collection form
(Appendix 2) which was piloted on three papers to ensure
suitability. Characteristics noted for each study are listed in
Appendix 2. The number of correct and incorrect diagnoses
made by both USS and iuMRwere also recorded as judged by
the ORD confirmed by postnatal imaging, autopsy or surgery.
Clinical examination was discounted as a reference standard
as the majority of structural brain abnormalities are not appar-
ent externally. Where studies reported the results of imaging
frommultiple anatomical areas, only results of the foetal brain
were included.
It was anticipated that all studies would recruit only (or
predominantly) foetuses with a brain abnormality diagnosed
by USS, meaning the sensitivity and specificity of the imaging
modalities could not be estimated because of the lack of foe-
tuses without brain abnormality. Therefore, the analysis de-
fined diagnostic accuracy for each modality as the percentage
of cases where the diagnosis was confirmed by ORD. In foe-
tuses with multiple abnormalities a primary diagnosis was
identified as the abnormality with the most detrimental clinical
outcome. In cases where both modalities identified the prima-
ry diagnosis but one provided amore specific diagnosis and/or
additional information without fundamentally changing the
primary diagnosis, our analysis assumed both modalities were
correct but the nature of disagreements was subsequently
investigated.
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Fig. 1 PRISMA flowchart of
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A meta-analysis of the diagnostic accuracy of iuMR in
relation to USS was conducted using the Stata statistical
analysis software [13]. For each study the odds ratio for
the paired iuMR and USS accuracies and its standard er-
ror were computed using the method of Becker and
Balagtas, using a 0.5 correction for zero cells [14, 15].
Odds ratios were combined using a random effects model
and the I2 statistic was used as an indicator of heteroge-
neity within the included studies [16, 17].
Results
Our initial searches generated a total of 1252 potential studies
with 807 remaining for additional scrutiny after duplicates
were removed. Further screening resulted in 34 published
studies for final inclusion [3, 18–50]. Categories for exclusion
of full papers reviewed but rejected are listed in the PRISMA
flowchart (Fig. 1).
Study characteristics
The 34 studies, listed in Table 1, were published over a
20-year period (1994–2014). Nineteen were prospective
[3, 18–35], 12 retrospective [36–47] and three unspecified
[48–50]. All studies selected a consecutive cohort of pa-
tients with either a remit to investigate all foetal brain
abnormalities (24 studies [3, 18–23, 29–32, 35, 39–41,
44–49]) or to investigate a more specific brain abnormal-
ity e.g. ventriculomegaly, corpus callosum anomalies (10
studies) [24–28, 34, 36, 38, 43, 50].
USS was performed in a tertiary centre and/or conduct-
ed by foetal medicine experts in 21/34 studies [3, 18–21,
26–29, 31, 32, 35–38, 40–43, 47], in 12/34 it was either
unclear or not specified [22–24, 30, 33, 34, 39, 45, 46,
48–50], and in one study [44] USS was performed in a
routine clinical setting. Clear details regarding USS tech-
nique (transabdominal or transvaginal, views obtained)
and equipment (manufacturer, transducer) were provided
in 21 studies [18–20, 22, 24–26, 28, 32–37, 39, 40, 42,
43, 47, 48, 50]. The remaining 13 studies [3, 21, 23, 27,
29–31, 38, 41, 44–46, 49] provided minimal information
or details were not given. Three out of 34 acknowledged
technical difficulties in some cases which limited the USS
[3, 28, 48]. The age range of foetuses reported across
studies was 13–41 weeks gestation. Time delay between
USS and iuMR was less than 2 weeks in 19/34 [3, 18–21,
23–25, 27, 30, 32, 33, 39, 41, 42, 44, 46, 47, 49] and not
specified in 13/34 studies [22, 26, 28, 29, 31, 34, 36, 38,
40, 43, 45, 48, 50]. In two studies [35, 37] there were
cases in which the time delay was greater than 2 weeks.
Experience of the clinician reporting the iuMR study
was only available in 10/34 studies [20, 21, 25, 27, 28,
30, 32, 35, 37, 42], half of these quantified this in terms
of years (between 1 and 15) the remaining gave a descrip-
tion of ‘experienced’. In two studies, the reporting radiol-
ogist was unaware of USS findings [21, 37]. Information
regarding MR technique was reported in all papers includ-
ing at least two of the following: manufacturer, sequences,
types of receiver coils and patient positioning. Fast T2-
weighted sequences were performed in all studies with
some using additional sequences (e.g. T1, DWI, 3D and
FLAIR). Early studies reported the use of fasting and
sedation to achieve optimal imaging [22, 34].
Methodological quality
The methodological quality assessments using the
Quadas 2 criteria are presented in Fig. 2. Risk of bias
for patient selection and applicability was low in 31/34
(91 %) studies [3, 18–45, 47, 50], high in one (6 %) [46]
and unclear in two [48, 49] with high risk of bias due to
patient selection criteria not being defined and retrospec-
tive study designs. The risk of bias due to conduct and
interpretation of the index tests was low risk in 15/34
(44 %) [3, 18, 20, 21, 25, 28, 30, 32, 35–37, 40, 42,
43, 47], high risk in 4/34 (12 %) [38, 44–46] and unclear
in 15/34 (44 %) [19, 22–24, 26, 27, 29, 31, 33, 34, 39,
41, 48–50]. Assessment of potential bias introduced by
the reference standard was considered low risk in 19/34
(56 %) studies [3, 18, 19, 21, 22, 24, 28–31, 35, 36, 38,
40, 44, 47–50], high risk in nine (26 %) [20, 27, 32–34,
41, 43, 45, 46] and unclear in 6/34 (18 %) [23, 25, 26,
37, 39, 42], as there were a proportion of cases within
the study that did not have a confirmed outcome or it
was determined by clinical examination. Bias in the flow
and timing as judged by timing between USS and iuMR
imaging or due to methods used for analysis of findings
was deemed low in 15/34 (42 %) [3, 18, 19, 23–25, 30,
32, 33, 35, 39, 46, 47, 49], high in 11/34 (32 %) [21, 26,
31, 34, 36–42] and unclear in 9/34 (27 %) [20, 22,
27–29, 44, 48, 50].
Diagnostic accuracy of US and MRI
The 34 included studies reported a combined total of
2530 foetuses (median 32.5, range 10–834) but of these
62 % (n = 1571) were excluded as they did not have an
iuMR (n = 796), 542 did not have an ORD, were non-
brain pathology (n = 159) or other exclusions (n = 74).
Consequently this systematic review reports on the out-
comes of 959 foetuses. In 6/34 studies [19, 28–30, 44,
49], all foetuses had an ORD, and combined contributed
186/959 to the analysis in this review (median 24.5,
range 12–72). The remaining 773/959 (median 38, range
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10–834) foetuses were from the outstanding 28 studies
[18, 20–27, 30–43, 45–48, 50].
The overall diagnostic accuracy combined across 34
studies was 75.2 % for USS and 91.0 % for iuMR (overall
odds ratio = 3.10, 95 % CI 1.98 to 4.86, p < 0.0001;
Fig. 3). Although individual studies were heterogeneous
(I2 = 45 %; p = 0.002), nearly all reported an improvement
in diagnostic accuracy following iuMR. The data are also
represented in the form of a L’Abbe plot (Fig. 4) in which
the diagnostic accuracies of iuMR and USS are presented
as percentages.
Agreement between USS and iuMR
The reports from USS and iuMR were in agreement and
agreed with the ORD in 527/959 (55 %). USS and iuMRwere
in agreement but discordant with the ORD in 52/959 (5.5 %)
foetuses (Table 1a and b, and 2).
In 160/959 (16.5 %) foetuses iuMR and USS were in
agreement regarding the primary diagnosis but additional
information was added—either secondary diagnoses or a
more concise/confident primary diagnosis given. In this
category iuMR provided additional information in 146/
959 (15 %) and USS provided additional information in
14/959 (1.5 %) cases as confirmed by ORD.
Disagreement between USS and iuMR
The diagnoses on iuMR and USS disagreed in 222
(23 %) cases. Of these, the iuMR was in agreement with
the ORD in 186 (19 %), the majority of which were
abnormalities undetected by USS (139/186, 75 %). The
remaining 47/186 (25 %) were abnormalities reported by
USS but correctly excluded by iuMR. In 34 cases the
USS diagnosis was incorrectly overturned by iuMR, 10
of which were abnormalities wrongly excluded or missed
by iuMR and 24/34 were abnormalities diagnosed by
iuMR but not found by USS or on the ORD (Table 2b
and 3b).
Table 3 presents the discordant diagnoses between
USS and iuMR according to category of anomaly. The
most frequent areas of disagreement were midline
(24 %) and posterior fossa abnormalities (21 %). In
particular agenesis of the corpus callosum and the
Dandy Walker spectrum of abnormalities were frequent-
ly missed or, less frequently, wrongly identified on
USS. The most frequently misdiagnosed anomalies on
both USS and iuMR were cortical formation abnormal-
ities (17 %) such as hemimegalencephaly, lissencephaly
and heterotopia.
Changes in counselling and management
Eleven studies [3, 18, 28–31, 40, 41, 44, 47, 48] reporting on
186 foetuses specified the benefit of iuMR in terms of changes
to counselling of parents or management of the pregnancy.
These changes as a result of findings on iuMR affected 78/
186 (41.9 %) foetuses.
Discussion
This systematic review and meta-analysis demonstrates
that using iuMR to support USS in the diagnosis of foetal
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Flow and Timing
Concern regarding Applicability of
Reference Standard
Reference Standard
Concern regarding Applicability of
Index Tests
Index Tests
Concern regarding Applicability of
Patient Selection
Patient Selection
High Low Unclear
Fig. 2 QUADAS risk of bias
assessment
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brain abnormalities increases diagnostic accuracy by 16 %
(75 % for USS alone and 91 % for iuMR as an adjunct).
The heterogeneity of the included studies was moderate
(I2 = 45 %, p = 0.002) according to the definitions of
Higgins et al. [51], suggesting methodological and clini-
cal variability and inconsistency in the measurement of
outcomes within each study. Although investigation of
heterogeneity is recommended [51], the ability to do so
is compromised by the lack of reporting (and indeed
quantification) of all the ways in which studies differ.
The performance of both diagnostic tests is influenced
by many factors, and a limitation of this review was in-
complete reporting of characteristics that would potential-
ly influence diagnostic performance such as operator ex-
perience (specified in just a third of included studies) and
technical difficulties (three studies) [3, 28, 48].
iuMR is not without its limitations and our review
demonstrated that iuMR overestimates the presence of ab-
normalities more frequently than failing to identify them.
This could be explained by the nature of foetal iuMR in
which the need for fast imaging compromises image qual-
ity. To the untrained eye artefacts from maternal breath-
ing, foetal movement and image aliasing may potentially
mimic or obscure pathology [52]. It is for this reason
‘experience’ should perhaps be defined by the number of
foetal brain examinations reported.
The timing of USS in relation to iuMR imaging is also
relevant in the assessment of both tests. The foetal brain
develops rapidly and significant delay between the two
examinations may influence the ability to diagnose accu-
rately either because of natural brain development, in-
crease in size of critical anatomical structures or because
NOTE: Weights are from random effects analysis
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of disease progression. Thirteen out of 34 studies failed to
report delay time, making an overall analysis of effect
from this criteria unreliable.
The extent to which iuMR ultimately contributes to
changes in management or in counselling regarding the
pregnancy is also unclear as this was only reported in a
small proportion of studies. Equally the impact of a wrong
diagnosis made by iuMR was not defined in any study
despite it occurring in 14/34 studies [18, 19, 21, 23, 26,
29, 33, 35, 36, 39–42, 44, 47].
Our review builds on the systematic reviews under-
taken by Rossi et al. and van Doorn. Rossi identified
2323 potential studies published between years 2000
and the end of 2012 and reviewed 13 studies (710 foe-
tuses), having excluded 2293 by title and abstract. Van
Doorn searched for publications between years 1990
and March 2014 and identified 2748 and excluded
2577 by title and abstract with 27 studies (1184 abnor-
malities detected by USS but only 454 with ORD)
reviewed. The differences of search dates and of exclu-
sion criteria, described earlier, appear to be the factors
resulting in the variation of studies reviewed by each
study.
An important difference between the two is that
Rossi restricted studies to those where outcomes were
confirmed by a reference diagnosis, although chose to
accept clinical examination as an ORD whereas van
Doorns’ selection criteria did not require an ORD. A
strength of our review was the requirement of an
ORD for any outcomes included in the meta-analysis.
As previously stated we excluded clinical examination
as an ORD. Although this significantly reduced the
number of outcomes available, we felt this was justified
as most structural brain abnormalities, and consequently
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diagnostic accuracy, cannot be determined with certainty
on clinical examination alone.
Our analysis included 34 studies, of which 15 were
additional to those included in the previous reviews owing
to more recent searches and differences in selection
criteria such as unlimited year of publication or sample
size within studies. Although Van Doorns’ searches were
unrestr icted by non-English publicat ions or the
requirement of an ORD, our review included more stud-
ies. This may be due to the limitation of sample size of
less than 20 by van Doorn, resulting in six additional
studies in this review, and the requirement of ‘adequate
description of diagnoses’ which was not clearly defined
by van Doorn.
Even with subtle differences in methods between all the
reviews, findings were similar. Rossi reported that iuMR
Table 2 Results of the number
and percentage of foetuses within
each category of outcome
Number Percentage
1a iuMR and USS agreed and correct 527 55
1b iuMR and USS agreed but incorrect 52 5.5
2a iuMR more exact/additional info to USS 146 15
2b iuMR changed incorrect USS diagnosis 186 19
Abnormalities identified correctly by iuMR but missed by USS 139
Abnormalities diagnosed by USS but correctly excluded by iuMR 47
3a USS more exact/additional info to iuMR 14 1.5
3b iuMR incorrectly changed correct USS diagnosis 34 4
Abnormalities diagnosed by USS but wrongly excluded by iuMR 10
Abnormalities overdiagnosed by iuMR that were absent on USS and ORD 24
Total 959
Table 3 Discordant diagnoses according to abnormality detected
Anomalies identified Abnormalities
identified
correctly by MRI
but missed by
US
Abnormalities
diagnosed by
US but correctly
excluded by
MRI
Abnormalities
diagnosed by
US but wrongly
excluded by
MRI
Abnormalities
overdiagnosed
by MRI that
were absent on
US and ORD
US and MRI
diagnoses both
wrong (either
missed or
overdiagnosed)
All
groups
Ventricular system (Ventriculomegaly,
aqueduct stenosis)
5 10 1 1 6 23
Neural tube defects (Anencephaly,
encephalocoele,
myelomeningocele)
5 5 0 1 1 12
Cortical formation abnormalities
(Hemi/megalencephaly,
schizencephaly, lissencephaly,
heterotopia, microcephaly)
21 3 3 5 14 46
Midline abnormalities
(Holoprosencephaly, agenesis/
hypogenesis of corpus callosum,
absent cavum septum)
39 15 2 1 7 64
Posterior fossa (Abnormalities: mega
cisterna magna, Blake’s pouch cyst,
Dandy-Walker or variant cerebellar
or vermian hypoplasia)
28 13 2 2 12 57
Vascular abnormalities (Haemorrhage,
haematoma dural fistula aneurysm)
17 0 1 1 20
Destructive or mass cerebral lesions
(Tumours, Cysts, PVL, other lesions,
dysplasias)
24 1 1 13 11 50
Totals 139 47 10 24 52
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was accurately able to identify brain abnormalities in 94.3 %
of included foetuses, van Doorn reported 80 % and our study
91 %, an increase of 15–20 % when compared to USS alone.
Both Rossi and van Doorn reported that the highest proportion
of disagreement between USS and iuMR was related to mid-
line abnormalities, particularly the posterior fossa. iuMR was
better able to diagnose abnormalities in this anatomical region,
also consistent with the findings of this systematic review
which incorporates a further four studies published since 2012.
Although heterogeneity was not quantified by Rossi
and van Doorn, both reviews highlighted the inadequate
reporting of study characteristics which may compromise
the findings of all systematic reviews. In order to ade-
quately assess the accuracy of a diagnostic test and deter-
mine its true benefit in clinical practice, optimal study
design is necessary [51].
We believe replication of the previous reviews is both
justified and necessary—it reassures that the minor differ-
ences in inclusion and exclusion criteria both at study
selection and data extraction do not change the outcomes
significantly, thus adding weight to the current evidence
base. In spite of the different nature of all the studies, the
diagnostic accuracy of iuMR was clearly superior across
the studies but the heterogeneity identified may compro-
mise these findings. The moderate level of heterogeneity
identified by our review warranted further investigation
but was prevented by insufficient reporting of study char-
acteristics. Despite its increasing use in clinical practice,
poor study design has previously brought into question
the diagnostic capabilities of iuMR above that which is
achieved by USS and its benefit in terms of guiding the
management of pregnancy and further studies are needed
[53]. For this reason we instigated the MERIDIAN [54]
project, a large prospective study to investigate iuMR im-
aging in the diagnosis of foetal brain abnormalities to
provide definitive evidence to guide future practice.
Conclusion
When foetal brain abnormalities are suspected on USS, iuMR
imaging is able to contribute significantly to the diagnostic
pathway by both clarifying findings and increasing signifi-
cantly the detection rate of abnormalities, particularly in mid-
line and posterior fossa anomalies. Limitations of previous
studies suggests that further investigation is still required to
clarify the full impact of iuMR.
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Appendix 1
Table 4 Medline search strategy
Database: Ovid MEDLINE(R) in-process & other
non-indexed citations, Ovid MEDLINE(R) Daily,
Ovid MEDLINE(R) and Ovid OLDMEDLINE(R)
<1946 to Present> Search Strategy:-
Results
(n)
1 Brain/ (381902) 381902
2 Abnormalities, Multiple/ 36708
3 1 and 2 1518
4 (brain adj5 abnormalit$).mp. 6920
5 Ventriculomegaly.mp. 1506
6 "Agenesis of Corpus Callosum"/ 1882
7 corpus callosum.mp. 15290
8 agenesis.mp. 10526
9 7 and 8 2720
10 Arnold-Chiari Malformation/ 2609
11 Chiari malformation.mp. 3070
12 Dandy-Walker syndrome/ 895
13 dandy walker.mp. 1258
14 3 or 4 or 5 or 6 or 9 or 10 or 11 or 12 or 13 16031
15 Fetus/ or Pregnancy/ 720818
16 Prenatal Diagnosis/ 31148
17 f?etus.mp. 115409
18 f?etal.mp. 306437
19 pregnan$.mp. 787645
20 in utero.mp. 21043
21 or/15-20 927013
22 Ultrasonography, Prenatal/ or Ultrasonography/ 86794
23 ultraso$.mp. 313296
24 22 or 23 313296
25 Magnetic Resonance Imaging/ 279781
26 (magnetic resonance imag$ or MRI).mp. 368017
27 25 or 26 368017
28 14 and 21 and 24 and 27 338
29 Comment/ 584249
30 Letter/ 840238
31 Editorial/ 355577
32 (comment or letter or editorial).pt. 1331667
33 case reports.pt. 1686033
34 29 or 30 or 31 or 32 or 33 2843406
35 28 not 34 204
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